230 related articles for article (PubMed ID: 26293116)
1. Peptidylarginine deiminase type 4 deficiency reduced arthritis severity in a glucose-6-phosphate isomerase-induced arthritis model.
Seri Y; Shoda H; Suzuki A; Matsumoto I; Sumida T; Fujio K; Yamamoto K
Sci Rep; 2015 Aug; 5():13041. PubMed ID: 26293116
[TBL] [Abstract][Full Text] [Related]
2. Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice.
Suzuki A; Kochi Y; Shoda H; Seri Y; Fujio K; Sawada T; Yamada R; Yamamoto K
BMC Musculoskelet Disord; 2016 May; 17():205. PubMed ID: 27150598
[TBL] [Abstract][Full Text] [Related]
3. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis.
Chang X; Yamada R; Suzuki A; Sawada T; Yoshino S; Tokuhiro S; Yamamoto K
Rheumatology (Oxford); 2005 Jan; 44(1):40-50. PubMed ID: 15466895
[TBL] [Abstract][Full Text] [Related]
4. Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase.
Iwanami K; Matsumoto I; Tanaka-Watanabe Y; Inoue A; Mihara M; Ohsugi Y; Mamura M; Goto D; Ito S; Tsutsumi A; Kishimoto T; Sumida T
Arthritis Rheum; 2008 Mar; 58(3):754-63. PubMed ID: 18311788
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms and functional haplotype in PADI4: further evidence for contribution on rheumatoid arthritis susceptibility and anti-cyclic citrullinated peptide antibodies in a western Mexican population.
Guzmán-Guzmán IP; Reyes-Castillo Z; Muñoz-Barrios S; Ruiz-Noa Y; Martínez-Bonilla GE; Parra-Rojas I; Palafox-Sánchez CA; Muñoz-Valle JF
Immunol Lett; 2015 Feb; 163(2):214-20. PubMed ID: 25562673
[TBL] [Abstract][Full Text] [Related]
6. The functional haplotype of peptidylarginine deiminase IV (S55G, A82V and A112G) associated with susceptibility to rheumatoid arthritis dominates apoptosis of acute T leukemia Jurkat cells.
Hung HC; Lin CY; Liao YF; Hsu PC; Tsay GJ; Liu GY
Apoptosis; 2007 Mar; 12(3):475-87. PubMed ID: 17216583
[TBL] [Abstract][Full Text] [Related]
7. Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study.
Hoppe B; Häupl T; Gruber R; Kiesewetter H; Burmester GR; Salama A; Dörner T
Arthritis Res Ther; 2006; 8(2):R34. PubMed ID: 16469113
[TBL] [Abstract][Full Text] [Related]
8. Peptidylarginine Deiminase 4 Promotes the Renal Infiltration of Neutrophils and Exacerbates the TLR7 Agonist-Induced Lupus Mice.
Hanata N; Shoda H; Hatano H; Nagafuchi Y; Komai T; Okamura T; Suzuki A; Gunarta IK; Yoshioka K; Yamamoto K; Fujio K
Front Immunol; 2020; 11():1095. PubMed ID: 32655553
[TBL] [Abstract][Full Text] [Related]
9. The Prominent Role of Hematopoietic Peptidyl Arginine Deiminase 4 in Arthritis: Collagen- and Granulocyte Colony-Stimulating Factor-Induced Arthritis Model in C57BL/6 Mice.
Fukui S; Gutch S; Fukui S; Cherpokova D; Aymonnier K; Sheehy CE; Chu L; Wagner DD
Arthritis Rheumatol; 2022 Jul; 74(7):1139-1146. PubMed ID: 35166055
[TBL] [Abstract][Full Text] [Related]
10. [Peptidylarginine deiminase type4 (PADI4) role in immune system].
Seri Y; Shoda H; Matsumoto I; Sumida T; Fujio K; Yamamoto K
Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(3):154-9. PubMed ID: 24974927
[TBL] [Abstract][Full Text] [Related]
11. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.
Bawadekar M; Shim D; Johnson CJ; Warner TF; Rebernick R; Damgaard D; Nielsen CH; Pruijn GJM; Nett JE; Shelef MA
J Autoimmun; 2017 Jun; 80():39-47. PubMed ID: 28188029
[TBL] [Abstract][Full Text] [Related]
12. Citrullinated vimentin stimulates proliferation, pro-inflammatory cytokine secretion, and PADI4 and RANKL expression of fibroblast-like synoviocytes in rheumatoid arthritis.
Fan LY; He DY; Wang Q; Zong M; Zhang H; Yang L; Sun LS
Scand J Rheumatol; 2012 Oct; 41(5):354-8. PubMed ID: 22765310
[TBL] [Abstract][Full Text] [Related]
13. [The significance of serum peptidylarginine deiminase 4 in rheumatoid arthritis].
Qian L; Shi HX; Li XP; Zhang H; Li XM; Wang GS
Zhonghua Nei Ke Za Zhi; 2011 Feb; 50(2):107-10. PubMed ID: 21418828
[TBL] [Abstract][Full Text] [Related]
14. Peptidylarginine deiminase 4 and citrullination in health and disease.
Anzilotti C; Pratesi F; Tommasi C; Migliorini P
Autoimmun Rev; 2010 Jan; 9(3):158-60. PubMed ID: 19540364
[TBL] [Abstract][Full Text] [Related]
15. Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis.
Cha S; Choi CB; Han TU; Kang CP; Kang C; Bae SC
Arthritis Rheum; 2007 May; 56(5):1454-63. PubMed ID: 17469103
[TBL] [Abstract][Full Text] [Related]
16. The inhibition of antithrombin by peptidylarginine deiminase 4 may contribute to pathogenesis of rheumatoid arthritis.
Chang X; Yamada R; Sawada T; Suzuki A; Kochi Y; Yamamoto K
Rheumatology (Oxford); 2005 Mar; 44(3):293-8. PubMed ID: 15561738
[TBL] [Abstract][Full Text] [Related]
17. [Suppression of GPI-induced arthritis by oral administration of transgenic rice seeds expressing altered peptide ligands].
Hirota T; Tsuboi H; Takahashi H; Asashima H; Ohta M; Wakasa Y; Matsumoto I; Takaiwa F; Sumida T
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):28-34. PubMed ID: 28539551
[TBL] [Abstract][Full Text] [Related]
18. Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis.
Hoppe B; Häupl T; Egerer K; Gruber R; Kiesewetter H; Salama A; Burmester GR; Dörner T
Ann Rheum Dis; 2009 Jun; 68(6):898-903. PubMed ID: 18633125
[TBL] [Abstract][Full Text] [Related]
19. PAD4 is not essential for disease in the K/BxN murine autoantibody-mediated model of arthritis.
Rohrbach AS; Hemmers S; Arandjelovic S; Corr M; Mowen KA
Arthritis Res Ther; 2012 May; 14(3):R104. PubMed ID: 22551352
[TBL] [Abstract][Full Text] [Related]
20. Peptidylarginine deiminase 4 (PADI4) identified as a conformation-dependent autoantigen in rheumatoid arthritis.
Takizawa Y; Sawada T; Suzuki A; Yamada R; Inoue T; Yamamoto K
Scand J Rheumatol; 2005; 34(3):212-5. PubMed ID: 16134727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
